Allergy Therapeutics (Allergy Therapeutics) Total Liabilities : $53.94 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Allergy Therapeutics Total Liabilities?

Allergy Therapeutics's Total Liabilities for the quarter that ended in Dec. 2023 was $53.94 Mil.

Allergy Therapeutics's quarterly Total Liabilities increased from Dec. 2022 ($40.99 Mil) to Jun. 2023 ($81.70 Mil) but then declined from Jun. 2023 ($81.70 Mil) to Dec. 2023 ($53.94 Mil).

Allergy Therapeutics's annual Total Liabilities declined from Jun. 2021 ($55.48 Mil) to Jun. 2022 ($43.33 Mil) but then increased from Jun. 2022 ($43.33 Mil) to Jun. 2023 ($81.70 Mil).

Allergy Therapeutics Total Liabilities Historical Data

The historical data trend for Allergy Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Total Liabilities Chart

Allergy Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Liabilities

Get a 7-Day Free Trial

39.21

53.12

55.48

43.33

81.70

Allergy Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															49.20	43.33	40.99	81.70	53.94

Allergy Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Allergy Therapeutics's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	23.441	+	(43.164	+	4.908
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	10.183)
	=	81.70

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	84.304	-	2.609
	=	81.70

Allergy Therapeutics's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	31.99	+	(10.253	+	0.706
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	10.994)
	=	53.94

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	87.439	-	33.496
	=	53.94

Allergy Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Allergy Therapeutics (Allergy Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (OTCPK:AGYTF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

AGY:UK HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.